Malaysia, Singapore and Indonesia In-Vitro Diagnostics (IVD) Market Report 2022 with Market Share of Leading Players - Roche, Abbott, Siemens Healthineers, Beckman Coulter, bioMerieux, Bio-Rad, Sysmex

News provided by

Dec 28, 2022, 07:45 ET

DUBLIN, Dec. 28, 2022 /PRNewswire/ -- The "In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022" report has been added to ResearchAndMarkets.com's offering.

This report focuses on three IVD markets in Southeast Asia: Malaysia, Indonesia, and Singapore.

The Asia Pacific (APAC) region is a fast-growing in vitro diagnostics (IVD) market, which is witnessing increasing focus by leading global players in the market. Southeast Asia has been identified as one of the key regions in APAC region offering significant opportunities for IVD companies.

These three countries together represent a fast-growing geographic region offering significant opportunity for IVD companies. The total population of these three countries is over 310 million, which is close to the population in the United States.

Among these three countries, Singapore has established world class healthcare service capabilities in terms of infrastructure as well as skilled manpower. Though the population is less than 6 million, the Singapore market is attractive for IVD companies and it has become a medical tourism hub in the region.

Indonesia, on the other hand, is a country with a huge population of about 275 million people. The country is taking significant steps to improve its healthcare infrastructure, which is offering considerable opportunities for IVD companies.

The Malaysian market, with a population of about 32 million falls in between these two countries, both in terms of healthcare service capabilities and growth potentials.

In Vitro Diagnostics (IVD) in Malaysia, Singapore, and Indonesia, 2022 covers the following segments:

POC
Clinical Chemistry
Immunoassays
Molecular Assays
Hematology
Coagulation
Microbiology and Virology
Blood Testing and Typing
Histology and Cytology

The report also profiles key companies in the market:

Abbott Diagnostics
ARKRAY
Beckman Coulter, Inc. / Danaher
Becton, Dickinson, and Company (BD)
BioCytech Corporation
bioMerieux Inc.
Bio-Rad Laboratories, Inc.
Caris Life Sciences
Cephei
CTK Biotech Inc
Danaher Corporation
Dexcom
DiaSorin S.p.A
Grifols S.A.
Healgen Scientific LLC
Hologic, Inc.
Horiba Medical
Lucence Diagnostics
Medical Innovation Ventures Sdn. Bhd. (Mediven)
Mindray (Shenzhen Mindray Bio-medical Electronics Co., Ltd.)
MiRXES Pte Ltd.
OraSure Technologies, Inc.
Ortho Clinical Diagnostics (Ortho)
PerkinElmer, Inc. (PE)
QIAGEN
Reszon Diagnostics International
Roche Diagnostics
Sysmex Corporation
Vela Diagnostics
Veredus Laboratories Pte Ltd

Key Topics Covered:

Chapter 1: Executive Summary

Malaysia: Healthcare and Regulatory Landscape
Regulation of Medical devices in Malaysia
IVD Market Size Estimation and Forecast for Malaysia
Indonesia: Healthcare and Regulatory Landscape
Market Drivers and Challenges
The Health Insurance System
Policies on Procurement, Import, Market Authorization, and Halal Certification of IVDs
IVD Market Size Estimation and Forecast for Indonesia
Singapore: Healthcare and Regulatory Landscape
The Health Insurance System
Policies on Import, Registration, and Distribution of IVDs in Singapore
Recovery of the Medical Tourism Sector
IVD Market Size Estimation and Forecast for Singapore
The Combined IVD Markets of Malaysia, Indonesia, and Singapore
Total IVD Market Size in Malaysia, Indonesia, and Singapore and Forecasts, 2022-2027 ($ Millions)
Market Shares of the Leading IVD Companies (Roche, Abbott, Siemens Healthineers, Beckman Coulter, bioMerieux, Bio-Rad, Sysmex, and Others) in Malaysia, Indonesia, and Singapore, 2022

Chapter 2: COVID-19 Testing Market Trends

COVID-19 Testing Trends in Malaysia (2020-2022)
COVID-19 Testing Trends in Indonesia (2020-2022)
COVID-19 Testing Trends in Singapore (2020-2022)

Chapter 3: Point-of-Care Tests

Pregnancy and Fertility Testing
Cancer Testing
Lipid Testing
Drug of Abuse (DOA) Testing
Infectious Disease Testing
HIV
Hepatitis
Tuberculosis (TB)
Tropical Diseases
Dengue
Filariasis
Leptospirosis
Malaria
Typhoid
Respiratory Diseases
Sexual Health
Diabetes Testing - Blood Glucose Monitoring
Other POC tests

Chapter 4: Core Lab and Clinical Chemistry

Workstation Consolidation and Laboratory Automation
Core Lab: Market Analysis
Clinical Chemistry Market Analysis
Blood Gases and Electrolytes
Urinalysis

Chapter 5: Immunoassays

Cardiac Markers
Tumor Markers
Diabetes
Thyroid
Autoimmune Diseases
Other Immunoassay Segments

Chapter 6: Molecular Assays

Oncology
Genetic Diseases and Disorders
Prenatal Testing, Pre-Implantation Genetic Testing, etc.
Transplant Diagnostics
Leading Companies (Roche, Abbott, QIAGEN, and Others) in the Molecular Diagnostics (Non-Infectious Diseases) Markets in Malaysia, Indonesia, and Singapore, 2022

Chapter 7: Hematology

Laboratory-based Hematology: Technology and Market Trends
Leading Companies (Sysmex, Beckman Coulter/Danaher, Mindray, Roche, and Others) in the Laboratory-based Hematology Markets in Malaysia, Indonesia, and Singapore, 2022

Chapter 8: Coagulation

Impact of COVID-19
Lab-based Coagulation Testing

Chapter 9: Microbiology and Virology

Antibiotic Resistant Infections: Challenges and Solutions
Syndromic Testing
Diagnosis of Prevalent Infectious Diseases in Malaysia, Indonesia, and Singapore
Hepatitis Testing
Sepsis and Hospital Acquired Infections (HAI) Testing
HIV Testing
Sexually Transmitted Diseases (STDs) Testing
ToRCH
Respiratory Infection Testing
Clinical Microbiology and Virology Market Segments
Tuberculosis (TB) Testing
Other Prevalent Infectious Diseases and their Diagnosis in Malaysia, Indonesia, and Singapore
ID/AST: Market Analysis
ID/AST Systems: Panels, Auto, and Supplies
Blood Culture
Chromogenic Media
Rapid Tests Performed on Colonies from Culture Media